HAV & B19 Testing Services
A Tender Notice
by NHS BLOOD AND TRANSPLANT
- Source
- Find a Tender
- Type
- Contract (Services)
- Duration
- 7 year
- Value
- £6M
- Sector
- HEALTH
- Published
- 12 Jul 2023
- Delivery
- 19 Oct 2023 to 18 Oct 2030
- Deadline
- 22 Aug 2023 16:00
Concepts
Location
Bristol: Manchester
1 buyer
- NHS Blood & Transplant Bristol
Description
This Contract notice is a call for competition and is separate to any tender opportunity. Its purpose is to inform the market of a tender opportunity. NHS Blood and Transplant are looking for a fully integrated high throughput testing solution for the detection of hepatitis A virus (HAV) RNA and Parvovirus B19 DNA in partnership with NHSBT. Additionally, the solution must also be able to test for HBV DNA, HIV-1 RNA, HIV-2 RNA, HCV RNA, HEV RNA as contingency during a business continuity need for NHSBTs .
Renewal Options
Maximum of 5 year extension.
Award Criteria
price | _ |
CPV Codes
- 71900000 - Laboratory services
- 48921000 - Automation system
- 33141625 - Diagnostic kits
- 33696500 - Laboratory reagents
- 33124110 - Diagnostic systems
- 33140000 - Medical consumables
- 33124000 - Diagnostics and radiodiagnostic devices and supplies
- 33696200 - Blood-testing reagents
- 33127000 - Immuno-analysis devices
- 33000000 - Medical equipments, pharmaceuticals and personal care products
Indicators
- This is a one-off contract (no recurrence)
- Renewals are available.
Other Information
The solution must have the relevant UKCA marking to support this ability.Participation is subject to the Supplier currently participating in the NHSBT KEG process, or confirmation that their testing solution has previously been KEG approved to deliver HAV & B19 Screening Services in partnership with NHSBT. All correspondence to: tennille.madigan@nhsbt.nhs.uk ** PREVIEW NOTICE, please check Find a Tender for full details. **
Reference
- ocds-h6vhtk-03e147
- FTS 020006-2023